Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Shorting stocks: High fliers -- Ignore unavailable to you. Want to Upgrade?

To: chester lee who wrote (426)	12/11/1997 8:44:00 AM
From: ref	Respond to of 709

Chester - you might try E-Trade if you still want to pursue this one. BTW, I attended a breast cancer conference last week, with speakers and attendees from around the country. No one I spoke with was familiar with this device/product, and I did not see a PR booth. Admittedly, I didn't canvass everyone. Still haven't seen any reference to this product in the surgical literature, FWIW. It still seems unlikely to me that this product will be prescribed much, since it doesn't look like it will, anytime soon, help establish a medicolegal standard of practice. If it could be marketed OTC, though, it might present a problem to shorts. I'm still concerned about the recent price run-up, which seems to be fairly sustained; can't figure what fueled this. Any ideas?